Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE2
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1